Cargando…

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals

Two doses of BNT162b2 mRNA vaccine induces a strong systemic SARS-CoV-2 specific humoral response. However, SARS-CoV-2 airborne transmission makes mucosal immune response a crucial first line of defense. Therefore, we characterized SARS-CoV-2-specific IgG responses induced by BNT162b2 vaccine, as we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longet, Stephanie, Hargreaves, Alexander, Healy, Saoirse, Brown, Rebecca, Hornsby, Hailey R., Meardon, Naomi, Tipton, Tom, Barnes, Eleanor, Dunachie, Susanna, Duncan, Christopher J. A., Klenerman, Paul, Richter, Alex, Turtle, Lance, de Silva, Thushan I., Carroll, Miles W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499336/ https://www.ncbi.nlm.nih.gov/pubmed/36159846 http://dx.doi.org/10.3389/fimmu.2022.953949

Ejemplares similares

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
por: Angyal, Adrienn, et al.
Publicado: (2022)

Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
por: Jay, Cecilia, et al.
Publicado: (2023)

T cell immune memory after covid-19 and vaccination
por: Wang, Lulu, et al.
Publicado: (2023)

Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
por: Phillips, Eloise, et al.
Publicado: (2022)

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
por: Hargreaves, Alexander, et al.
Publicado: (2021)

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
por: Neale, Isabel, et al.
Publicado: (2023)

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
por: Hornsby, Hailey, et al.
Publicado: (2023)

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
por: Jay, Cecilia, et al.
Publicado: (2023)

Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
por: Mellors, Jack, et al.
Publicado: (2020)

Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection
por: Longet, Stephanie, et al.
Publicado: (2021)

Pre-clinical models to define correlates of protection for SARS-CoV-2
por: Brady, Caolann, et al.
Publicado: (2023)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
por: Payne, Rebecca P., et al.
Publicado: (2021)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
por: Barnes, Eleanor, et al.
Publicado: (2023)

Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells?
por: Longet, Stephanie, et al.
Publicado: (2023)

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
por: Moore, Shona C., et al.
Publicado: (2023)

Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
por: Johnson, Síle A, et al.
Publicado: (2023)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network
por: Murray, Sam, et al.
Publicado: (2022)

P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY
por: Jer Lim, Yeong, et al.
Publicado: (2023)

Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
por: Williams, Daniel M., et al.
Publicado: (2023)

Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men
por: Osborne, Brendan J. W., et al.
Publicado: (2017)

Naïve to expert: Considering the role of previous knowledge in memory
por: Alonso, Alejandra, et al.
Publicado: (2020)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
por: Skelly, Donal T., et al.
Publicado: (2021)

Incidence of Delirium With Different Oral Opioids in Previously Opioid-Naive Patients
por: Sugiyama, Yosuke, et al.
Publicado: (2022)

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2023)

Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia
por: Kohoutova, Darina, et al.
Publicado: (2020)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Ever closer to a prophylactic vaccine for HCV
por: Swadling, Leo, et al.
Publicado: (2013)

Modified vaccinia Ankara–Bavarian Nordic vaccine against mpox in children
por: Turtle, Lance, et al.
Publicado: (2023)

1163: BOTH VEDOLIZUMAB AND ANTI-TNF THERAPY ARE ASSOCIATED WITH ATTENUATION OF SEROLOGICAL AND NEUTRALIZING RESPONSES TO SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE
por: Wellens, Judith, et al.
Publicado: (2022)

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
por: Huo, Jiandong, et al.
Publicado: (2023)

Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohort
por: Silva, C, et al.
Publicado: (2010)

Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
por: Lundgren, Anna, et al.
Publicado: (2023)

Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques
por: Sui, Yongjun, et al.
Publicado: (2018)

Endoscopic transcecal appendectomy for recurrent appendicitis after previous endoscopic mucosal resection
por: Ma, Zhi-Lan, et al.
Publicado: (2023)

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
por: de Silva, Thushan I., et al.
Publicado: (2021)

Mucosal-Associated Invariant T-Cells: New Players in Anti-Bacterial Immunity
por: Ussher, James E., et al.
Publicado: (2014)

The double burden of diabetes and global infection in low and middle-income countries
por: Dunachie, Susanna, et al.
Publicado: (2019)

Local cytokine transcription in naïve and previously infected sheep and lambs following challenge with Teladorsagia circumcincta
por: Craig, Nicola M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3o6ie0omcidsdcv5o0bhojq9eb